CLINICAL_TRIALS
withdrawal
· 2025-06-05
Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
Summary
A pilot study by ProgenaBiome evaluating the role of gut flora in Epidermolysis Bullosa has been withdrawn. The study covered Epidermolysis Bullosa and its subt…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ProgenaBiome | Conditions: Epidermolysis Bullosa, Epidermolysis Bullosa Simplex | Status: WITHDRAWN